Yifeng Pharmacy Chain Co., Ltd.
Research Yifeng Pharmacy Chain Co., Ltd. (603939.SS) on Bullrun: market cap CNY 30.41B, P/E 17.5, dividend yield 2.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker603939.SS
- ExchangeSS
- CountryChina
- SectorHealthcare
- IndustryPharmaceutical Retailers
- CurrencyCNY
- Market capCNY 30.41B
- P/E17.5
- Dividend yield2.7%
- Financial periodQ2 2026
- RevenueCNY 6.04B
- Net incomeCNY 464.23M
- Free cash flowCNY 344.95M
- Gross margin40.6%
Valuation Snapshot
latest market cap is CNY 30.41B; P/E is 17.5; dividend yield is 2.7%.
Peer valuation comparison
Latest P/E is 17.54x versus a Healthcare sector median of 21.69x (19.1% below).
Latest dividend yield is 2.72% versus a Healthcare sector median of 2.41% (12.9% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | CNY 30.41B | 17.5 | 2.8% | 0.7 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.7 CNY, yield 2.7%.
About Yifeng Pharmacy Chain Co., Ltd.
Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. The company offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to health.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Yifeng Pharmacy Chain Co., Ltd.'s market cap?
Yifeng Pharmacy Chain Co., Ltd.'s market capitalization is CNY 30.41B.
What is Yifeng Pharmacy Chain Co., Ltd.'s P/E ratio?
Yifeng Pharmacy Chain Co., Ltd.'s price-to-earnings (P/E) ratio is 17.5.
Does Yifeng Pharmacy Chain Co., Ltd. pay a dividend?
Yifeng Pharmacy Chain Co., Ltd. has a dividend yield of 2.7%.
What does Yifeng Pharmacy Chain Co., Ltd. do?
Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. The company offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to health. It is also involved in chronic disease management, medical project investment, and medical technology development, as well as operates internet hospitals and clinics.